Snowball logo
logo
BIOA

BioAge Labs, Inc

BIOA NASDAQ
$19.885-$0.185  (0.92%)

Frequently asked questions

What sector does BioAge Labs, Inc (BIOA) operate in?

BioAge Labs, Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is BioAge Labs, Inc (BIOA) current stock price?

As of the latest data, BioAge Labs, Inc stock price is $19.89, with a previous close of $20.07. BioAge Labs, Inc lost -$0.19 in the last trading session, representing a -0.92% loss.

What is BioAge Labs, Inc (BIOA) current market capitalization?

BioAge Labs, Inc market cap is approximately 830.25 million.

What is BioAge Labs, Inc (BIOA) Earnings Per Share (EPS)?

The trailing EPS is $13.61, and the forward EPS is -$2.61.

What is BioAge Labs, Inc (BIOA) Price-to-Earnings (P/E) ratio?

BioAge Labs, Inc current P/E ratio is 1.46.

What is BioAge Labs, Inc (BIOA) EBITDA?

BioAge Labs, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -19.97 million.

Does BioAge Labs, Inc (BIOA) pay dividends?

No. BioAge Labs, Inc does not pay a dividend.

How did BioAge Labs, Inc (BIOA) perform in its most recent earnings report?

In the last report (September 30, 2025), BioAge Labs, Inc posted an EPS surprise of -9.01% and a revenue surprise of 164.18%.

When is BioAge Labs, Inc (BIOA) next earnings report?

BioAge Labs, Inc is expected to release its next earnings report on December 31, 2025.

What is BioAge Labs, Inc (BIOA) beta (volatility) score?

BioAge Labs, Inc has a beta of 0.348, indicating lower volatility than the overall market.